Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ENDRA Life Sciences Inc. (NDRA : NSDQ)

• Company Description    ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. Number of Employees: 11

• Price / Volume Information    Yesterday's Closing Price: $4.86 Daily Weekly Monthly 20 Day Moving Average: 36,947 shares Shares Outstanding: 1.27 (millions) Market Capitalization: $6.17 (millions) Beta: -0.06 52 Week High: $9.85 52 Week Low: $2.96 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 13.02% 12.19% 12 Week -0.21% -2.94% Year To Date 7.29% 6.68%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3600 GREEN COURT SUITE 350 - ANN ARBOR,MI 48105 USA ph: 734-335-0468 fax: - ybriggs@allianceadvisors.com http://www.endrainc.com

• General Corporate Information    Officers Alexander Tokman - Chief Executive Officer and Chairman Richard Jacroux - Chief Financial Officer Louis J. Basenese - Director Anthony DiGiandomenico - Director Michael Harsh - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 29273B500 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 1.27 Most Recent Split Date: 11.00 (0.03:1) Beta: -0.06 Market Capitalization: $6.17 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.84 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-4.11 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.37 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 35.91% vs. Previous Quarter: 0.60% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/26 - - 03/31/26 - -433.64 12/31/25 - -397.71 ROA 06/30/26 - - 03/31/26 - -204.58 12/31/25 - -190.73 Current Ratio 06/30/26 - - 03/31/26 - 0.64 12/31/25 - 1.29 Quick Ratio 06/30/26 - - 03/31/26 - 0.64 12/31/25 - 1.29 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Book Value 06/30/26 - - 03/31/26 - 1.44 12/31/25 - 1.92 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©